Status:
COMPLETED
Microscopic Peritoneal Metastases After Complete Macroscopic Cytoreductive Surgery for Epithelial Ovarian Cancer
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Epithelial Ovarian Cancer
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The objective of the cytoreductive surgery carried out for the management of ovarian cancers is to obtain a complete macroscopic cytoreduction. This means that all visible peritoneal metastases must b...
Detailed Description
Understanding biology and progression mechanisms of peritoneal metastases (PM) of epithelial ovarian cancer (EOC) is a cornerstone in the knowledge and the comprehensive management of the disease, as ...
Eligibility Criteria
Inclusion
- Age \> 18 years-old, French nationality
- with epithelial ovarian or tubal cancer
- Complete macroscopic cytoreductive surgery (CC-0) regardless of the sequence compared to chemotherapy.
- Patient giving express consent
Exclusion
- Borderline ovarian tumor
- Incomplete cytoreductive surgery
- Pregnant women
- Major under guardianship / trusteeship,
- Not insured
Key Trial Info
Start Date :
June 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 10 2019
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03754569
Start Date
June 1 2018
End Date
July 10 2019
Last Update
October 21 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpitaux Universitaires Pitié Salpêtrière - Charles Foix
Paris, France, 75013